Patent · US Active

Method to form a dialysis composition comprising citrate, calcium and magnesium

US9724298B2 · kind B2 · utility

20Cited by

6References

12Claims

0Family size

Assignee

GAMBRO LUNDIA AB · SE

Inventors

Anders Nilsson · Västerås, SE
Jan Sternby · Lund, SE
Anders Wieslander · Lund, SE

Key dates

Filing date	Jun 29, 2016
Grant date	Aug 8, 2017
Priority date	—
Expiry date	Jun 29, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M1/1654
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method to form a dialysis composition includes determining for a patient a prescribed calcium concentration for a dialysis fluid to be administered to the patient. The determination is made based on a non-citrate containing calcium dialysis fluid. 0.5 to 3 mM citrate and 1 to 5 mM total calcium are introduced to the dialysis fluid. The total calcium results in a calcium concentration that is 0.1 to 0.2 mM per 1 mM citrate greater than the prescribed calcium concentration. 0 to 1.5 mM total magnesium is introduced to the dialysis fluid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.